1. Rippe B, Venturoli D, Simonsen O et al. Fluid and electrolyte transport across the peritoneal membrane during CAPD according to the three-pore model. Perit Dial Int 2004; 24: 10–27.
2. Krediet RT. Fluid absorption in the peritoneum – it is less simple than you thought. Nephrol Dial Transplant 1994; 9: 341–343.
3. Coester AM, Parikova A, Smit W et al. Mechanisms in ultrafiltration failure of long‑term peritoneal dialysis patients. Port J Nephrol Hypert 2008; 22: 217–220.
4. Daugirdas JT, Ing TS, Gandhi VC et al. Kinetics of peritoneal fluid absorption in patients with chronic renal failure. J Lab Clin Med 1980; 95: 351–361.
5. Struijk DG, Krediet RT, Imholz AL et al. Fluid kinetics in CAPD patients during dialysis with a bicarbonate‑based hypoosmolar solution. Blood Purif 1996; 14: 217–226.
6. Krediet RT, Struijk DG, Koomen GC et al. Peritoneal fluid kinetics during CAPD measured with intraperitoneal dextran 70. ASAIO Trans 1991; 37: 662–667.
7. Smit W, van Dijk P, Langedijk MJ et al. Peritoneal function and assessment of reference values using a 3.86% glucose solution. Perit Dial Int 2003; 23: 440–449.
8. Ho-Dac-Pannekeet MM, Schouten N, Langendijk MJ et al. Peritoneal transport characteristics with glucose polymer based dialysate. Kidney Int 1996; 50: 979–986.
9. Pecoits-Filho R, Mujais S, Lindholm B. Future of icodextrin as an osmotic agent in peritoneal dialysis. Kidney Int Suppl 2002; 81: S80–S87.
10. Imholz AL, Brown CB, Koomen GC et al. The effect of glucose polymers on water removal and protein clearances during CAPD. Adv Perit Dial 1993; 9: 25–30.
11. Tomo T. Peritoneal dialysis solutions low in glucose degradation products-evidence for clinical benefits. Perit Dial Int 2008; 28 (Suppl 3): S123–S127.
12. Moberly JB, Mujais S, Gehr T et al. Pharmacokinetics of icodextrin in peritoneal dialysis patients. Kidney Int Suppl 2002; 81: S23–S33.
13. Gokal R, Moberly J, Lindholm B et al. Metabolic and laboratory effects of icodextrin. Kidney Int Suppl 2002; 81: S62–S71.
14. Mistry CD, Fox JE, Mallick NP et al. Circulating maltose and isomaltose in chronic renal failure. Kidney Int Suppl 1987; 22: S210–S214.
15. Mistry CD, Gokal R. The use of glucose polymer (icodextrin) in peritoneal dialysis: an overview. Perit Dial Int 1994; 14 (Suppl 3): S158–S161.
16. de Waart DR, Zweers MM, Struijk DG et al. Icodextrin degradation products in spent dialysate of CAPD patients and the rat, and its relation with dialysate osmolality. Perit Dial Int 2001; 21: 269–274.
17. de Fijter CW, Verbrugh HA, Oe LP et al. Biocompatibility of a glucose‑polymer-containing peritoneal dialysis fluid. Am J Kidney Dis 1993; 21: 411–418.
18. Cooker LA, Choo CG, Luneburg P et al. Effect of icodextrin peritoneal dialysis solution on cell proliferation in vitro. Adv Perit Dial 1999; 15: 17–20.
19. MacGinley R, Cooney K, Alexander G et al. Relapsing culture‑negative peritonitis in peritoneal dialysis patients exposed to icodextrin solution. Am J Kidney Dis 2002; 40: 1030–1035.
20. Imholz AL, Brown CB, Koomen GC et al. The effect of glucose polymers on water removal and protein clearances during CAPD. Adv Perit Dial 1993; 9: 25–30.